Received Feb 19, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| FLU3 | INFLUENZA (SEASONAL) (FLULAVAL) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 79K45 | — |
patient was 4 months old at that time), and was administered a FluLaval vaccine; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 6-month-old female patient who received Flu Seasonal TIV Quebec (FluLaval 2024-2025 season) (batch number 79K45, expiry date 01-JUN-2025) for prophylaxis. On 13-NOV-2024, the patient received FluLaval 2024-2025 season. On 13-NOV-2024, an unknown time after receiving FluLaval 2024-2025 season, the patient experienced inappropriate age at vaccine administration (Verbatim: patient was 4 months old at that time), and was administered a FluLaval vaccine). The outcome of the inappropriate age at vaccine administration was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 24-JAN-2025 The medical assistant reported that a patient who was currently 6 months old was seen in clinic on 13-Nov-2024 (patient was 4 months old at that time), and was administered a FluLaval vaccine, which led to inappropriate age at vaccine administration. At that time no one caught that the patient was too young for the vaccine, now the patient was back in clinic for 6 month visit and the error was discovered. The medical assistant reports the patient was fine and had no reactions. The vaccine administration facility was the same as primary reporter.